Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - CASH FROM OPERATIONS
Cash from Operations RARE - Ultragenyx Pharmaceutical Inc.
-414 M
LAST VALUE
-4.34%
2 YEAR CAGR
-3.70%
5 YEAR CAGR
-24.95%
10 YEAR CAGR